Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rusal named the terms of construction of the second stage of the Boguchansk plant

10/4/24 RUAL

SPX Exchange plans to hold at least five IPOs in 2025

10/4/24 SPBE

Chizhik plans to reach ₽1 trillion in revenue by 2028

10/4/24 X5

TGC-14 increased electricity generation by 11%

10/4/24 TGKN

SR Space failed to raise the planned ₽1.53 billion

10/4/24 MOEX

SR Space failed to raise the planned ₽1.53 billion

10/4/24 OTCI

Promsvyazbank set the buyout price for CarMoney shares

10/4/24 CARM

Renaissance Insurance bought Raiffeisen Life

10/4/24 RENI

Fesco will remain the single logistics operator of the Vostochny terminal

10/3/24 FESH

Sollers' sales in January - September grew by 18%

10/3/24 SVAV